Haisco Pharmaceutical Group
Research-based pharmaceutical company with commercial and clinical programs in anesthesia, metabolic disease and neurology.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Non-cystic Fibrosis Bronchiectasis
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPDPhase 3 · Recruiting · COPD (Chronic Obstructive Pulmonary Disease)
Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgANPhase 3 · Recruiting · IgA Nephropathy (IgAN)
A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis BronchiectasisPhase 3 · Recruiting · Non-cystic Fibrosis Bronchiectasis
A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASHPhase 3 · Recruiting · MASH - Metabolic Dysfunction-Associated Steatohepatitis
A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective SurgeryPhase 4 · Recruiting · Anesthesia
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/haisco-pharmaceutical-group/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.